Cargando…
Mebendazole prevents distant organ metastases in part by decreasing ITGβ4 expression and cancer stemness
Breast cancer is the most diagnosed cancer among women. Approximately 15–20% of all breast cancers are highly invasive triple-negative breast cancer (TNBC) and lack estrogen, progesterone, and ERBB2 receptors. TNBC is challenging to treat due to its aggressive nature with far fewer targeted therapie...
Autores principales: | Joe, Natalie S., Godet, Inês, Milki, Nubaira, Ain, Noor U. I., Oza, Harsh H., Riggins, Gregory J., Gilkes, Daniele M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798635/ https://www.ncbi.nlm.nih.gov/pubmed/36578038 http://dx.doi.org/10.1186/s13058-022-01591-3 |
Ejemplares similares
-
Mebendazole Treatment Disrupts the Transcriptional Activity of Hypoxia-Inducible Factors 1 and 2 in Breast Cancer Cells
por: Joe, Natalie S., et al.
Publicado: (2023) -
Preventative Effect of Mebendazole against Malignancies in Neurofibromatosis 1
por: Staedtke, Verena, et al.
Publicado: (2020) -
6th GMA-ITG Fachtagung Sensoren
por: Verein Deutscher Ingenieure. Düsseldorf, et al.
Publicado: (1992) -
Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
por: Williamson, Tara, et al.
Publicado: (2021) -
ITG: A New Global GNSS Tropospheric Correction Model
por: Yao, Yibin, et al.
Publicado: (2015)